William Blair & Company’s St Jude Medical STJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
Sell
-2,976
Closed -$239K 1546
2016
Q4
$239K Sell
2,976
-2,140
-42% -$170K ﹤0.01% 1090
2016
Q3
$408K Buy
5,116
+23
+0.5% +$1.86K ﹤0.01% 900
2016
Q2
$397K Sell
5,093
-1,404
-22% -$100K ﹤0.01% 884
2016
Q1
$357K Hold
6,497
﹤0.01% 886
2015
Q4
$401K Sell
6,497
-12,525
-66% -$790K ﹤0.01% 870
2015
Q3
$1.2M Buy
19,022
+1,776
+10% +$127K 0.01% 698
2015
Q2
$1.26M Sell
17,246
-1,400
-8% -$101K ﹤0.01% 1514
2015
Q1
$1.22M Sell
18,646
-11,900
-39% -$791K ﹤0.01% 1495
2014
Q4
$1.99M Sell
30,546
-7,984
-21% -$514K ﹤0.01% 1293
2014
Q3
$2.32M Sell
38,530
-3,875
-9% -$253K ﹤0.01% 1216
2014
Q2
$2.94M Sell
42,405
-11,697
-22% -$758K ﹤0.01% 1136
2014
Q1
$3.54M Buy
54,102
+43,122
+393% +$2.81M 0.01% 1044
2013
Q4
$679K Sell
10,980
-2,100
-16% -$122K ﹤0.01% 1493
2013
Q3
$701K Sell
13,080
-350
-3% -$18K ﹤0.01% 1447
2013
Q2
$613K Buy
+13,430
New +$582K ﹤0.01% 1438

Other funds holding STJ

William Blair & Company's STJ Position: Q1 2017 in Review

William Blair & Company sold out of St Jude Medical (STJ) in Q1 2017, closing a stake of 2,976 shares — an estimated $239K sold.

William Blair & Company first reported a position in STJ in Q2 2013 and held it in 15 quarters. The position peaked at $3.54M in Q1 2014. 4 funds tracked by Wall St. Rank hold STJ as of Q1 2017.

  • William Blair & Company reported no remaining St Jude Medical position as of Q1 2017 after selling out during the quarter.
  • William Blair & Company sold 2,976 St Jude Medical shares in Q1 2017, an estimated $239K.
  • William Blair & Company first reported a position in St Jude Medical in Q2 2013 and held it in 15 quarters.
  • William Blair & Company's St Jude Medical position peaked at $3.54M in Q1 2014.
  • 4 funds tracked by Wall St. Rank held St Jude Medical as of Q1 2017.

Based on William Blair & Company's 13F filing for Q1 2017, filed 10 May 2017.